Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy

NCT00101426 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy

Interventions

DRUG: ranirestat, (AS-3201)

Sponsor

Sumitomo Pharma Co., Ltd.